Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2035-75-8

Post Buying Request

2035-75-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2035-75-8 Usage

Uses

Adipic Anhydride is an esterifier for food starch in combination with acetic anhydride.

Check Digit Verification of cas no

The CAS Registry Mumber 2035-75-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,0,3 and 5 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 2035-75:
(6*2)+(5*0)+(4*3)+(3*5)+(2*7)+(1*5)=58
58 % 10 = 8
So 2035-75-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H8O3/c1-2-3-4-5(7)9-6(4)8/h4H,2-3H2,1H3

2035-75-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name ADIPIC ANHYDRIDE

1.2 Other means of identification

Product number -
Other names Hexahydrooxepin-2,7-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2035-75-8 SDS

2035-75-8Synthetic route

hexanedioic acid dimethyl ester
627-93-0

hexanedioic acid dimethyl ester

A

1,6-hexanediol
629-11-8

1,6-hexanediol

B

adipic anhydride
2035-75-8

adipic anhydride

Conditions
ConditionsYield
With water; hydrogen In methanol under 37503.8 Torr;A 8.3%
B 89.1%
Adipic acid
124-04-9

Adipic acid

adipic anhydride
2035-75-8

adipic anhydride

Conditions
ConditionsYield
With thionyl chloride; sodium carbonate In 1,4-dioxane; dichloromethane for 3h; Heating;84%
Stage #1: Adipic acid With acetic anhydride at 160℃; for 4h;
Stage #2: zinc diacetate at 100 - 200℃;
82.5%
Stage #1: Adipic acid With acetic anhydride at 160℃; for 4h; Heating / reflux;
Stage #2: zinc diacetate at 100 - 200℃;
82.5%
Adipic acid
124-04-9

Adipic acid

acetic anhydride
108-24-7

acetic anhydride

adipic anhydride
2035-75-8

adipic anhydride

Conditions
ConditionsYield
In acetic anhydride for 14h; Heating / reflux;56%
cyclohexanone-2-ol
533-60-8

cyclohexanone-2-ol

A

Adipic acid
124-04-9

Adipic acid

B

adipic anhydride
2035-75-8

adipic anhydride

C

cyclohexane-1,2-dione
765-87-7

cyclohexane-1,2-dione

Conditions
ConditionsYield
With air; chromium(III)naphthenate In chlorobenzene at 50℃; Product distribution; var. catalyst;A 54%
B 43%
C 3%
hexanedioic acid dimethyl ester
627-93-0

hexanedioic acid dimethyl ester

A

6-Hydroxyhexanoic acid
1191-25-9

6-Hydroxyhexanoic acid

B

adipic acid monomethyl ester
627-91-8

adipic acid monomethyl ester

C

adipic anhydride
2035-75-8

adipic anhydride

Conditions
ConditionsYield
With hydrogen In 1,4-dioxane under 37503.8 Torr;A 34.1%
B 42.3%
C 21%
hexahydro-2H-oxepin-2-one
502-44-3

hexahydro-2H-oxepin-2-one

adipic anhydride
2035-75-8

adipic anhydride

Conditions
ConditionsYield
With hydrogenchloride; tetrakis(tetrabutylammonium)decatungstate(VI); oxygen In water; acetonitrile at 20℃; for 0.75h; Flow reactor; Irradiation;41%
cyclohexane
110-82-7

cyclohexane

A

Adipic acid
124-04-9

Adipic acid

B

adipic anhydride
2035-75-8

adipic anhydride

C

mono(2-oxocyclohexyl)adipinate
76164-97-1

mono(2-oxocyclohexyl)adipinate

Conditions
ConditionsYield
With oxygen; cobalt naphthenate In chlorobenzene at 50℃; Kinetics; Product distribution; without catalyst in air;
cyclohexanone
108-94-1

cyclohexanone

A

hexahydro-2H-oxepin-2-one
502-44-3

hexahydro-2H-oxepin-2-one

B

2-ketocyclohexyl hydroperoxide
50915-79-2

2-ketocyclohexyl hydroperoxide

C

adipic anhydride
2035-75-8

adipic anhydride

D

cyclohexane-1,2-dione
765-87-7

cyclohexane-1,2-dione

E

mono(2-oxocyclohexyl)adipinate
76164-97-1

mono(2-oxocyclohexyl)adipinate

F

cyclohexanone-2-ol
533-60-8

cyclohexanone-2-ol

Conditions
ConditionsYield
With oxygen In chlorobenzene at 120℃; for 8h; Mechanism; tested presence of cobalt naphthenate;
cyclohexanone-2-ol
533-60-8

cyclohexanone-2-ol

A

Adipic acid
124-04-9

Adipic acid

B

adipic anhydride
2035-75-8

adipic anhydride

Conditions
ConditionsYield
With oxygen In chlorobenzene at 50℃; Mechanism; var. solvents; also in the presence of diphenyl sulfide (DPS) and cyclohexanol;
cyclohexanone-2-ol
533-60-8

cyclohexanone-2-ol

A

Adipic acid
124-04-9

Adipic acid

B

5-formylvaleric acid
928-81-4

5-formylvaleric acid

C

adipic anhydride
2035-75-8

adipic anhydride

D

cyclohexane-1,2-dione
765-87-7

cyclohexane-1,2-dione

Conditions
ConditionsYield
With oxygen; cobalt naphthenate In chlorobenzene at 50℃; Kinetics; Product distribution; without catalyst in air;
cyclohexanone-2-ol
533-60-8

cyclohexanone-2-ol

A

Adipic acid
124-04-9

Adipic acid

B

adipic anhydride
2035-75-8

adipic anhydride

C

cyclohexane-1,2-dione
765-87-7

cyclohexane-1,2-dione

D

monoperoxyadipic acid
77155-29-4

monoperoxyadipic acid

E

2-hydroxy-2-hydroperoxycyclohexanone
81485-24-7

2-hydroxy-2-hydroperoxycyclohexanone

F

mono(2-oxocyclohexyl)adipinate
76164-97-1

mono(2-oxocyclohexyl)adipinate

Conditions
ConditionsYield
With oxygen In chlorobenzene at 50℃; Product distribution; Rate constant;
With 2,2'-azobis(isobutyronitrile); oxygen In chlorobenzene at 49.84℃; Kinetics; Concentration;
cyclohexanone-2-ol
533-60-8

cyclohexanone-2-ol

A

Adipic acid
124-04-9

Adipic acid

B

adipic anhydride
2035-75-8

adipic anhydride

C

cyclohexane-1,2-dione
765-87-7

cyclohexane-1,2-dione

D

2-hydroxy-2-hydroperoxycyclohexanone
81485-24-7

2-hydroxy-2-hydroperoxycyclohexanone

E

mono(2-oxocyclohexyl)adipinate
76164-97-1

mono(2-oxocyclohexyl)adipinate

Conditions
ConditionsYield
With air In chlorobenzene at 95℃; Kinetics;
polymer(ic) form

polymer(ic) form

adipic anhydride
2035-75-8

adipic anhydride

Conditions
ConditionsYield
under 0.1 Torr; Bei der Destillation; monomer(ic) form;
cis-1,2-cyclohexane
1792-81-0

cis-1,2-cyclohexane

A

Adipic acid
124-04-9

Adipic acid

B

5-formylvaleric acid
928-81-4

5-formylvaleric acid

C

adipic anhydride
2035-75-8

adipic anhydride

D

6,6-dihydroxy-hexanal

6,6-dihydroxy-hexanal

Conditions
ConditionsYield
With dihydrogen peroxide; TAPO-5 In water at 80℃; for 24h; Further byproducts given;
2-methoxymethylenecyclohexanone
15839-18-6

2-methoxymethylenecyclohexanone

adipic anhydride
2035-75-8

adipic anhydride

Conditions
ConditionsYield
With ozone In dichloromethane at -70℃; for 0.075h;
cyclohexene
110-83-8

cyclohexene

A

Adipic acid
124-04-9

Adipic acid

B

adipic anhydride
2035-75-8

adipic anhydride

C

oxepane-2,7-diol

oxepane-2,7-diol

Conditions
ConditionsYield
With dihydrogen peroxide In methanol; water at 90℃; for 18h; Catalytic behavior;
cyclohexanone
108-94-1

cyclohexanone

A

hexahydro-2H-oxepin-2-one
502-44-3

hexahydro-2H-oxepin-2-one

B

adipic anhydride
2035-75-8

adipic anhydride

Conditions
ConditionsYield
With N-hydroxyphthalimide; ammonium cerium (IV) nitrate; oxygen In acetonitrile at 45℃; under 760.051 Torr; Baeyer-Villiger Ketone Oxidation;
methanol
67-56-1

methanol

adipic anhydride
2035-75-8

adipic anhydride

hexanedioic acid dimethyl ester
627-93-0

hexanedioic acid dimethyl ester

Conditions
ConditionsYield
In dichloromethane at 20℃; for 24h;100%
adipic anhydride
2035-75-8

adipic anhydride

aripiprazole
129722-12-9

aripiprazole

C29H35Cl2N3O5

C29H35Cl2N3O5

Conditions
ConditionsYield
With dmap In toluene at 100℃; for 42h; Temperature; Solvent;96.2%
adipic anhydride
2035-75-8

adipic anhydride

N1-methyl-4-nitrobenzene-1,2-diamine
41939-61-1

N1-methyl-4-nitrobenzene-1,2-diamine

Adipinsaeure-2-methylamino-5-nitro-monoanilid
128183-75-5

Adipinsaeure-2-methylamino-5-nitro-monoanilid

Conditions
ConditionsYield
In chloroform for 2h; Heating;95%
piperidine
110-89-4

piperidine

adipic anhydride
2035-75-8

adipic anhydride

pentane-5'-carboxy-(1'-piperidinyl)-carboxamide
347142-76-1

pentane-5'-carboxy-(1'-piperidinyl)-carboxamide

Conditions
ConditionsYield
In dichloromethane for 5h; Heating;95%
1-methyl-piperazine
109-01-3

1-methyl-piperazine

adipic anhydride
2035-75-8

adipic anhydride

pentane-5'-carboxy-[1-(4'-N-methylpiperazinyl)]-carboxamide
75727-47-8

pentane-5'-carboxy-[1-(4'-N-methylpiperazinyl)]-carboxamide

Conditions
ConditionsYield
In dichloromethane for 5h; Heating;95%
3,5-dimethyl-4-nitroisoxazole
1123-49-5

3,5-dimethyl-4-nitroisoxazole

adipic anhydride
2035-75-8

adipic anhydride

C11H14N2O3

C11H14N2O3

Conditions
ConditionsYield
With tin; phosphomolybdic acid In methanol at 80℃; for 2h;94%
adipic anhydride
2035-75-8

adipic anhydride

2-(Diethylamino)ethanol
100-37-8

2-(Diethylamino)ethanol

bis[2-(diethylamino)ethyl] adipate
16545-00-9

bis[2-(diethylamino)ethyl] adipate

Conditions
ConditionsYield
With titanium (IV) oxysulfate In 5,5-dimethyl-1,3-cyclohexadiene at 80 - 145℃; for 3.5h; Reagent/catalyst; Temperature; Solvent; Concentration;91.1%
adipic anhydride
2035-75-8

adipic anhydride

clarithromycin
81103-11-9

clarithromycin

C44H77NO16

C44H77NO16

Conditions
ConditionsYield
With dmap In chloroform at 110℃; for 8h; Temperature;91%
adipic anhydride
2035-75-8

adipic anhydride

4-Aminobenzonitrile
873-74-5

4-Aminobenzonitrile

6-[(4-cyanophenyl)amino]-6-oxohexanoic acid
1156221-43-0

6-[(4-cyanophenyl)amino]-6-oxohexanoic acid

Conditions
ConditionsYield
In tetrahydrofuran Reflux;90%
trimethylsilylazide
4648-54-8

trimethylsilylazide

adipic anhydride
2035-75-8

adipic anhydride

5-isocyanatopentanoic acid trimethylsilyl ester
57467-25-1

5-isocyanatopentanoic acid trimethylsilyl ester

Conditions
ConditionsYield
In 1,4-dioxane for 0.333333h; Heating;87%
In 1,4-dioxane for 0.166667h; Heating;76%
(+)-Paliperidone
130049-85-3

(+)-Paliperidone

adipic anhydride
2035-75-8

adipic anhydride

trifluoroacetic acid
76-05-1

trifluoroacetic acid

C29H35FN4O6*C2HF3O2

C29H35FN4O6*C2HF3O2

Conditions
ConditionsYield
Stage #1: (+)-Paliperidone; adipic anhydride With dmap; triethylamine In dichloromethane at 20℃; for 1h;
Stage #2: trifluoroacetic acid In water; acetonitrile pH=4;
87%
adipic anhydride
2035-75-8

adipic anhydride

4-nitro-aniline
100-01-6

4-nitro-aniline

N-(4-nitro-phenyl)-adipamic acid
5502-65-8

N-(4-nitro-phenyl)-adipamic acid

Conditions
ConditionsYield
In 1,4-dioxane Heating;86%
adipic anhydride
2035-75-8

adipic anhydride

maytan-3-O-carbamoyl-N-(4-aminobenzene)

maytan-3-O-carbamoyl-N-(4-aminobenzene)

maytan-3-O-carbamoyl-N-phenyl-p-amino-adipic acid

maytan-3-O-carbamoyl-N-phenyl-p-amino-adipic acid

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran; N,N-dimethyl-formamide at 20℃; for 18h; Sealed tube; Inert atmosphere;86%
methanol
67-56-1

methanol

adipic anhydride
2035-75-8

adipic anhydride

ethyl 2-phenylpropanoate
2510-99-8

ethyl 2-phenylpropanoate

C18H24O5

C18H24O5

Conditions
ConditionsYield
Stage #1: adipic anhydride With aluminum (III) chloride In dichloromethane Reflux;
Stage #2: ethyl 2-phenylpropanoate In dichloromethane Reflux;
Stage #3: methanol In dichloromethane
84.8%
methanol
67-56-1

methanol

bromobenzene
108-86-1

bromobenzene

adipic anhydride
2035-75-8

adipic anhydride

methyl 4-bromo-ε-oxobenzenehexanoate
90991-25-6

methyl 4-bromo-ε-oxobenzenehexanoate

Conditions
ConditionsYield
Stage #1: adipic anhydride With aluminum (III) chloride In dichloromethane Reflux;
Stage #2: bromobenzene In dichloromethane Reflux;
Stage #3: methanol In dichloromethane
84.6%
C11H16N2O2S2
886973-47-3

C11H16N2O2S2

adipic anhydride
2035-75-8

adipic anhydride

C17H24N2O5S2
886973-48-4

C17H24N2O5S2

Conditions
ConditionsYield
In dichloromethane at 22℃; for 8h;84%
N-(6-(diethylamino)-9-(2-(piperazine-1-carbonyl)phenyl)-3H-xanthen-3-ylidene)-N-ethylethanaminium 2,2,2-trifluoroacetate
1100365-01-2

N-(6-(diethylamino)-9-(2-(piperazine-1-carbonyl)phenyl)-3H-xanthen-3-ylidene)-N-ethylethanaminium 2,2,2-trifluoroacetate

adipic anhydride
2035-75-8

adipic anhydride

N-(9-(2-(4-(5-carboxypentanoyl)piperazine-1-carbonyl)phenyl)-6-(diethylamino)-3H-xanthen-3-ylidene)-N-ethylethanaminium 2,2,2-trifluoroacetate

N-(9-(2-(4-(5-carboxypentanoyl)piperazine-1-carbonyl)phenyl)-6-(diethylamino)-3H-xanthen-3-ylidene)-N-ethylethanaminium 2,2,2-trifluoroacetate

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane for 2h; Inert atmosphere;84%
adipic anhydride
2035-75-8

adipic anhydride

C128H204N5O21P

C128H204N5O21P

C134H214N3O24P

C134H214N3O24P

Conditions
ConditionsYield
Stage #1: C128H204N5O21P With acetic acid; zinc In dichloromethane at 20℃; for 6h;
Stage #2: adipic anhydride With 4-methyl-morpholine In dichloromethane at 20℃; for 12h; pH=> 7;
82%
adipic anhydride
2035-75-8

adipic anhydride

benzyl alcohol
100-51-6

benzyl alcohol

adipic acid monobenzyl ester
40542-90-3

adipic acid monobenzyl ester

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 20℃;81%
In dichloromethane at 20℃; for 2h;
adipic anhydride
2035-75-8

adipic anhydride

(S)-1-amino-2-(methoxymethyl)pyrrolidine
59983-39-0

(S)-1-amino-2-(methoxymethyl)pyrrolidine

(S)-1-[2-(methoxymethyl)pyrrolidin-1-yl]azepane-2,7-dione
1643933-19-0

(S)-1-[2-(methoxymethyl)pyrrolidin-1-yl]azepane-2,7-dione

Conditions
ConditionsYield
Stage #1: adipic anhydride; (S)-1-amino-2-(methoxymethyl)pyrrolidine In dichloromethane at 20℃; for 1h; Inert atmosphere;
Stage #2: With sodium acetate; acetic anhydride In dichloromethane for 5h; Heating; Inert atmosphere;
78%
adipic anhydride
2035-75-8

adipic anhydride

(3Z,6Z,10E)-11,15-Dimethyl-hexadeca-3,6,10,14-tetraen-1-ol
130727-74-1

(3Z,6Z,10E)-11,15-Dimethyl-hexadeca-3,6,10,14-tetraen-1-ol

Hexanedioic acid mono-((3Z,6Z,10E)-11,15-dimethyl-hexadeca-3,6,10,14-tetraenyl) ester
130727-75-2

Hexanedioic acid mono-((3Z,6Z,10E)-11,15-dimethyl-hexadeca-3,6,10,14-tetraenyl) ester

Conditions
ConditionsYield
With pyridine; dmap In dichloromethane at 0℃; for 3h;75%
adipic anhydride
2035-75-8

adipic anhydride

1-myristoyl-2-lyso-sn-glycero-3-phosphatidylcholine
13699-45-1

1-myristoyl-2-lyso-sn-glycero-3-phosphatidylcholine

C26H50NO10P

C26H50NO10P

Conditions
ConditionsYield
With pyridine; benzotriazol-1-ol In tetrahydrofuran at 20℃; Inert atmosphere;75%
4-(5-fluoro-1H-benzo[d]imidazol-2-yl)aniline
872552-44-8

4-(5-fluoro-1H-benzo[d]imidazol-2-yl)aniline

adipic anhydride
2035-75-8

adipic anhydride

6-((4-(5-fluoro-1H-benzo[d]imidazol-2-yl)phenyl)amino)-6-oxohexanoic acid

6-((4-(5-fluoro-1H-benzo[d]imidazol-2-yl)phenyl)amino)-6-oxohexanoic acid

Conditions
ConditionsYield
In tetrahydrofuran at 160 - 170℃; Molecular sieve; Microwave irradiation;74%
adipic anhydride
2035-75-8

adipic anhydride

4-(5-methoxy-1H-benzo[d]imidazol-2-yl)aniline

4-(5-methoxy-1H-benzo[d]imidazol-2-yl)aniline

6-((4-(5-methoxy-1H-benzo[d]imidazol-2-yl)phenyl)amino)-6-oxohexanoic acid

6-((4-(5-methoxy-1H-benzo[d]imidazol-2-yl)phenyl)amino)-6-oxohexanoic acid

Conditions
ConditionsYield
In tetrahydrofuran at 160 - 170℃; Molecular sieve; Microwave irradiation;71%
adipic anhydride
2035-75-8

adipic anhydride

(3Z,6Z)-Heptadeca-3,6-dien-1-ol
130727-73-0

(3Z,6Z)-Heptadeca-3,6-dien-1-ol

Hexanedioic acid mono-((3Z,6Z)-heptadeca-3,6-dienyl) ester
130727-91-2

Hexanedioic acid mono-((3Z,6Z)-heptadeca-3,6-dienyl) ester

Conditions
ConditionsYield
With pyridine; dmap In dichloromethane at 0℃; for 3h;70%
adipic anhydride
2035-75-8

adipic anhydride

2-(4-aminophenyl)pyrido<3,2-d>imidazole

2-(4-aminophenyl)pyrido<3,2-d>imidazole

6-((4-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl)amino)-6-oxohexanoic acid

6-((4-(1H-imidazo[4,5-b]pyridin-2-yl)phenyl)amino)-6-oxohexanoic acid

Conditions
ConditionsYield
In tetrahydrofuran at 160 - 170℃; Molecular sieve; Microwave irradiation;69%
adipic anhydride
2035-75-8

adipic anhydride

maytan-NMA-(4-amino)benzamide

maytan-NMA-(4-amino)benzamide

maytansin-N-methyl-L-alanine-N-(4-amino)benzamide-adipic acid

maytansin-N-methyl-L-alanine-N-(4-amino)benzamide-adipic acid

Conditions
ConditionsYield
With pyridine at 20℃; for 4h; Inert atmosphere; Sealed tube;67%

2035-75-8Relevant articles and documents

-

Hill

, p. 4110,4113 (1930)

-

Preparation method 6 -hydroxy caproic acid

-

Paragraph 0056-0060; 0093; 0095-0098; 0107; 0109-0112, (2021/11/10)

The invention provides a preparation method of 6 -hydroxycaproic acid. The method comprises the following steps: 1) subjecting 1 and 6 - adipic acid to intramolecular dehydration to obtain adipic anhydride. 2) The adipic acid anhydride is reacted with fatty alcohol to obtain the adipic acid monoester. 3) The adipic acid monoester was subjected to a reduction reaction under hydrogen pressure to give 6 - hydroxycaproic acid. 1-hydroxycaproic acid is prepared by taking 6 - and 6 - adipic acid cheap and easily available as raw materials through intramolecular dehydration, ring opening esterification, hydrogenation reduction and the like.

Evodiamine prodrug containing indole quinone unit as well as preparation method and application thereof

-

Paragraph 0026, (2021/10/30)

The invention relates to an evodiamine prodrug containing an indole quinone unit as well as a preparation method and application thereof. The invention synthesizes a series of strong active evodiamine derivatives with indole quinine units, has strong anti-proliferative activity on non-small cell lung cancer (non-small cell lung cancer, NSCLC), and has dosage and time dependence. In-vitro experiments evaluate their biological activity, suggesting that the synthesized compounds have a strong inhibitory activity on lung cancer strains. Through molecular docking analysis, the binding affinity of the ligand to the active site of the target protein is predicted, and the interaction ability of the ligand and the protein is strong.

Oxidation of KA oil to caprolactone with molecular oxygen using N-hydroxyphthalimide-mediated Ce(NH4)2(NO3)6 catalyst

Du, Renfeng,Yuan, Haoran,Yao, Jia,Li, Haoran

, p. 24 - 29 (2019/02/03)

In traditional Baeyer-Villiger oxidation, peracids or hydrogen peroxide are usually adopted as the oxidants. When molecular oxygen is used as oxidant, the sacrificial agents are always indispensable, such as aldehydes that are transformed into cheap acids after reaction. In this work, KA oil (the industrial raw material, a mixture of cyclohexanol and cyclohexanone) has been oxidized to caprolactone by molecular oxygen using N-hydroxyphthalimide (NHPI) and cerium ammonium nitrate (CAN) as catalyst, in which the sacrificial agent is cyclohexanol, and it is converted into cyclohexanone, then into caprolactone rather than into byproducts. The selectivity of caprolactone was 98% with cyclohexanol conversion of 34% and it was still kept at 90% when the conversion reached to 46%. The mechanism investigation showed a bifunctional role of CAN, which performed both as a radical initiator for cyclohexanol oxidation and a Lewis acid for Baeyer-Villiger reaction. In the Baeyer-Villiger oxidation, a weak interaction between cerium and cyclohexanone was suggested by Fourier Transform Infrared Spectroscopy (FTIR), meanwhile, the active species generated from cerium and hydrogen peroxide was separated and characterized by FTIR. The detailed research also revealed an unusual effect between cerium and the Br?nsted acid generated as a byproduct, which was critical for caprolactone synthesis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2035-75-8